Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Clorox Co (NYSE: CLX) closed at $120.38 in the last session, up 0.38% from day before closing price of $119.93. In other words, the price has increased by $0.38 from its previous closing price. On the day, 1.66 million shares were traded. CLX stock price reached its highest trading level at $120.67 during the session, while it also had its lowest trading level at $117.64.
Ratios:
We take a closer look at CLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 88.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.35. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.84. In the meantime, Its Debt-to-Equity ratio is 9.04 whereas as Long-Term Debt/Eq ratio is at 8.75.
On November 06, 2024, TD Cowen Upgraded its rating to Hold which previously was Sell and also upped its target price recommendation from $155 to $170. Jefferies Upgraded its Hold to Buy on October 01, 2024, whereas the target price for the stock was revised from $174 to $187.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 04 ’25 when Reynolds Eric H sold 15,041 shares for $123.78 per share. The transaction valued at 1,861,847 led to the insider holds 54,221 shares of the business.
Eric Reynolds bought 15,041 shares of CLX for $1,861,848 on Sep 04 ’25. On May 07 ’25, another insider, Breber Pierre R, who serves as the Director of the company, bought 4,000 shares for $136.57 each. As a result, the insider paid 546,285 and bolstered with 4,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 14723607552 and an Enterprise Value of 17633607680. As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.45, and their Forward P/E ratio for the next fiscal year is 17.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07 while its Price-to-Book (P/B) ratio in mrq is 46.01. Its current Enterprise Value per Revenue stands at 2.482 whereas that against EBITDA is 12.622.
Stock Price History:
The Beta on a monthly basis for CLX is 0.51, which has changed by -0.26133645 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, CLX has reached a high of $171.37, while it has fallen to a 52-week low of $116.53. The 50-Day Moving Average of the stock is -2.85%, while the 200-Day Moving Average is calculated to be -13.67%.
Shares Statistics:
According to the various share statistics, CLX traded on average about 1.92M shares per day over the past 3-months and 1917390 shares per day over the past 10 days. A total of 122.69M shares are outstanding, with a floating share count of 121.83M. Insiders hold about 0.39% of the company’s shares, while institutions hold 90.29% stake in the company. Shares short for CLX as of 1756425600 were 6947994 with a Short Ratio of 3.62, compared to 1753920000 on 6004320. Therefore, it implies a Short% of Shares Outstanding of 6947994 and a Short% of Float of 6.4899996.
Dividends & Splits
The forward annual dividend rate for CLX is 4.90, which was 4.9 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.040857166. The stock’s 5-year Average Dividend Yield is 3.05. The current Payout Ratio is 75.19% for CLX, which recently paid a dividend on 2025-08-13 with an ex-dividend date of 2025-10-22. Stock splits for the company last occurred on 1999-08-24 when the company split stock in a 2:1 ratio.
Earnings Estimates
A comprehensive evaluation of Clorox Co (CLX) is underway, with the input of 14.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $1.52, with high estimates of $1.74 and low estimates of $1.4.
Analysts are recommending an EPS of between $6.3 and $5.88 for the fiscal current year, implying an average EPS of $6.09. EPS for the following year is $6.9, with 17.0 analysts recommending between $7.76 and $6.38.
Revenue Estimates
According to 10 analysts, the current quarter’s revenue is expected to be $1.41B. It ranges from a high estimate of $1.45B to a low estimate of $1.39B. As of the current estimate, Clorox Co’s year-ago sales were $1.76BFor the next quarter, 10 analysts are estimating revenue of $1.66B. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.62B.
A total of 17 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $6.59B, while the lowest revenue estimate was $6.42B, resulting in an average revenue estimate of $6.52B. In the same quarter a year ago, actual revenue was $7.1BBased on 17 analysts’ estimates, the company’s revenue will be $6.8B in the next fiscal year. The high estimate is $6.95B and the low estimate is $6.68B.
